We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
-8.17%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$218M
AUM Growth
-$19.5M
Cap. Flow
+$3.51M
Cap. Flow %
1.61%
Top 10 Hldgs %
4.42%
Holding
1,001
New
307
Increased
177
Reduced
167
Closed
349

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$934K
2
MASI
Masimo
MASI
+$931K
3
PDYN icon
Palladyne AI
PDYN
+$929K
4
ELS icon
Equity Lifestyle Properties
ELS
+$926K
5
BWA icon
BorgWarner
BWA
+$898K

Top Sells

Rank Stock Value
1
CG icon
Carlyle Group
CG
+$962K
2
WGS icon
GeneDx Holdings
WGS
+$933K
3
VSAT icon
Viasat
VSAT
+$852K
4
INFA
Informatica
INFA
+$807K
5
AMGN icon
Amgen
AMGN
+$804K

Sector Composition

Rank Sector Weight
1 Healthcare 17.61%
2 Technology 17.16%
3 Industrials 15.49%
4 Financials 11.59%
5 Consumer Discretionary 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITOS
801
DELISTED
iTeos Therapeutics
ITOS
– –
-29,850
Closed -$229K
J icon
802
Jacobs Solutions
J
$15.9B
– –
-2,395
Closed -$317K
JANX icon
803
Janux Therapeutics
JANX
$935M
– –
-12,225
Closed -$655K
JBGS
804
JBG SMITH
JBGS
$846M
– –
-19,327
Closed -$297K
JBHT icon
805
JB Hunt Transport Services
JBHT
$27.1B
– –
-1,957
Closed -$334K
JBLU icon
806
JetBlue
JBLU
$1.96B
– –
-20,614
Closed -$162K
JJSF icon
807
J&J Snack Foods
JJSF
$1.43B
– –
-1,863
Closed -$289K
JKHY icon
808
Jack Henry & Associates
JKHY
$10.7B
– –
-3,605
Closed -$632K
JLL icon
809
Jones Lang LaSalle
JLL
$15.1B
– –
-823
Closed -$208K
JMIA
810
Jumia Technologies
JMIA
$726M
– –
-30,653
Closed -$117K
JSPR icon
811
Jasper Therapeutics
JSPR
$22.9M
– –
-10,431
Closed -$223K
KALU icon
812
Kaiser Aluminum
KALU
$2.67B
– –
-3,726
Closed -$262K
KALV
813
DELISTED
KalVista Pharmaceuticals
KALV
– –
-11,509
Closed -$97.5K
KHC icon
814
Kraft Heinz
KHC
$30.4B
– –
-9,055
Closed -$278K
KNF icon
815
Knife River
KNF
$4.43B
– –
-2,259
Closed -$230K
KNX icon
816
Knight Transportation
KNX
$11.8B
– –
-5,558
Closed -$295K
KROS icon
817
Keros Therapeutics
KROS
$199M
– –
-11,535
Closed -$183K
KSPI icon
818
Kaspi.kz JSC
KSPI
$16.3B
– –
-4,361
Closed -$413K
KT icon
819
KT
KT
$8.84B
– –
-18,660
Closed -$290K
KTB icon
820
Kontoor Brands
KTB
$4.62B
– –
-2,626
Closed -$224K
LAMR icon
821
Lamar Advertising Co
LAMR
$16.2B
– –
-2,801
Closed -$341K
LASR icon
822
nLIGHT
LASR
$3.95B
– –
-27,951
Closed -$293K
LAUR icon
823
Laureate Education
LAUR
$5.18B
– –
-23,914
Closed -$437K
LAZ icon
824
Lazard
LAZ
$4.37B
– –
-3,920
Closed -$202K
LBRT icon
825
Liberty Energy
LBRT
$2.83B
– –
-24,732
Closed -$492K
31 32
33
34 35

Similar funds

SFA
Seneca Financial Advisors Rochester, New York $341M AUM 14.73% 1-Year Est. Return
FCM
Findell Capital Management New York $341M AUM 135.6% 1-Year Est. Return
CPI
Crestview Partners II New York $341M AUM 17.29% 1-Year Est. Return
SW
SMART Wealth Omaha, Nebraska $341M AUM 24.37% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return
KFSC
Keystone Financial Services (Colorado) Loveland, Colorado $341M AUM 18.11% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
SC
Slotnik Capital Dallas, Texas $342M AUM 105.92% 1-Year Est. Return

EntryPoint Capital's Q1 2025 Portfolio in Review

As of Q1 2025, EntryPoint Capital held 1,001 positions worth $218M, down 8.2% from $238M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.

EntryPoint Capital's Q1 2025 filing shows 307 new, 177 increased, 167 reduced and 349 closed positions. Its largest new stake was AtriCure: 25,168 shares worth $812K. The largest sale was Carlyle Group, an estimated $962K.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

  • EntryPoint Capital's largest Q1 2025 buy was AtriCure: 25,168 shares worth $812K.
  • EntryPoint Capital added most to Amphenol in Q1 2025, an estimated $815K increase.
  • EntryPoint Capital's biggest Q1 2025 reduction was Harmony Biosciences, cutting an estimated $692K.
  • EntryPoint Capital fully exited Carlyle Group in Q1 2025, selling an estimated $962K.
  • EntryPoint Capital's ten largest holdings make up 4.4% of its $218M portfolio in Q1 2025.
  • EntryPoint Capital opened 307 new positions and closed 349 in Q1 2025.
  • EntryPoint Capital's portfolio value fell 8.2% quarter-over-quarter to $218M.

Based on EntryPoint Capital's 13F filing for Q1 2025, filed 14 May 2025.